title: Different effects of losartan and delapril on plasma PAI-1 levels in patients with mild to moderate hypertension.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Paterna
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Di Garbo
authors.forename: Gino
authors.initials: G
authors.lastname: Avellone
authors.forename: Pietro
authors.initials: P
authors.lastname: Di Pasquale
authors.forename: Antonio
authors.initials: A
authors.lastname: Tuttolomondo
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Follone
authors.forename: Antonietta
authors.initials: A
authors.lastname: Cardinale
authors.forename: Tiziana
authors.initials: T
authors.lastname: Maniscalchi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Licata
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D007189:Indans / Q000627:therapeutic use*; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007189:Indans; D017395:Plasminogen Activator Inhibitor 1; D019808:Losartan; C047759:delapril